US Stock MarketDetailed Quotes

Unicycive Therapeutics (UNCY)

Watchlist
  • 6.070
  • +0.210+3.58%
Close Dec 26 16:00 ET
  • 6.040
  • -0.030-0.49%
Post 20:01 ET
130.45MMarket Cap-3.79P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Unicycive Therapeutics (UNCY) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
-29.02%675K
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
-29.02%675K
--0
Cost of revenue
Gross profit
Operating expense
17.45%7.34M
-5.92%6.96M
-13.20%7.99M
49.74%32.12M
46.70%9.26M
5.27%6.25M
71.24%7.4M
88.72%9.2M
12.87%21.45M
18.55%6.31M
Selling and administrative expenses
36.56%4.38M
105.80%5.21M
143.33%5.82M
41.61%12.1M
91.01%3.97M
24.94%3.21M
23.26%2.53M
29.45%2.39M
30.15%8.55M
40.07%2.08M
-General and administrative expense
36.56%4.38M
105.80%5.21M
143.33%5.82M
41.61%12.1M
91.01%3.97M
24.94%3.21M
23.26%2.53M
29.45%2.39M
30.15%8.55M
40.07%2.08M
Research and development costs
-2.66%2.96M
-64.05%1.75M
-68.13%2.17M
55.12%20.01M
24.92%5.29M
-9.70%3.05M
114.73%4.87M
124.85%6.81M
3.75%12.9M
10.23%4.23M
Operating profit
-17.45%-7.34M
5.92%-6.96M
13.20%-7.99M
-54.60%-32.12M
-46.70%-9.26M
-5.27%-6.25M
-71.24%-7.4M
-119.04%-9.2M
-15.08%-20.77M
-18.55%-6.31M
Net non-operating interest income expense
-34.16%264K
-68.16%142K
330.61%211K
123.26%1.19M
142.98%294K
91.87%401K
120.79%446K
2,350.00%49K
8,983.33%533K
4,133.33%121K
Non-operating interest income
-32.93%279K
-66.45%155K
227.54%226K
105.04%1.26M
124.29%314K
83.26%416K
97.44%462K
392.86%69K
--615K
--140K
Non-operating interest expense
0.00%15K
-18.75%13K
-25.00%15K
-13.41%71K
5.26%20K
-16.67%15K
-50.00%16K
66.67%20K
1,266.67%82K
533.33%19K
Other net income (expense)
-39.17%1.07M
-97.78%374K
170.70%8.35M
43.69%-5.8M
-681.94%-12.56M
25.64%1.75M
5,860.99%16.81M
-13.81%-11.81M
-10.3M
-1.61M
Gain on sale of security
-39.17%1.07M
-97.78%374K
170.70%8.35M
43.69%-5.8M
-681.94%-12.56M
25.64%1.75M
5,860.99%16.81M
-13.81%-11.81M
---10.3M
---1.61M
Income before tax
-46.75%-6.01M
-165.42%-6.45M
102.72%570K
-20.25%-36.73M
-176.03%-21.53M
5.47%-4.1M
356.77%9.86M
-43.83%-20.96M
-69.14%-30.54M
-46.36%-7.8M
Income tax
Net income
-46.75%-6.01M
-165.42%-6.45M
102.72%570K
-20.25%-36.73M
-176.03%-21.53M
5.47%-4.1M
356.77%9.86M
-43.83%-20.96M
-69.14%-30.54M
-46.36%-7.8M
Net income continuous Operations
-46.75%-6.01M
-165.42%-6.45M
102.72%570K
-20.25%-36.73M
-176.03%-21.53M
5.47%-4.1M
356.77%9.86M
-43.83%-20.96M
-69.14%-30.54M
-46.36%-7.8M
Minority interest income
Net income attributable to the parent company
-46.75%-6.01M
-165.42%-6.45M
102.72%570K
-20.25%-36.73M
-176.03%-21.53M
5.47%-4.1M
356.77%9.86M
-43.83%-20.96M
-69.14%-30.54M
-46.36%-7.8M
Preferred stock dividends
26.30%1.1M
0
47.10%887K
8.33%208K
867K
0
Other preferred stock dividends
0
60K
5.93M
0
Net income attributable to common stockholders
-46.75%-6.01M
-311.86%-6.45M
102.41%510K
-20.42%-37.82M
-176.03%-21.53M
7.01%-4.1M
168.52%3.04M
-43.37%-21.17M
-73.95%-31.41M
-46.36%-7.8M
Basic earnings per share
28.26%-0.33
-165.00%-0.52
0
56.25%-5.6
-18.17%-1.8908
64.62%-0.46
127.59%0.8
37.11%-6.1
-6.67%-12.8
54.29%-1.6
Diluted earnings per share
28.26%-0.33
65.33%-0.52
91.80%-0.5
56.25%-5.6
-18.17%-1.8908
64.62%-0.46
48.28%-1.5
37.11%-6.1
-6.67%-12.8
54.29%-1.6
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 00000000-29.02%675K0
Operating revenue --0--0--0--0--0--0--0--0-29.02%675K--0
Cost of revenue
Gross profit
Operating expense 17.45%7.34M-5.92%6.96M-13.20%7.99M49.74%32.12M46.70%9.26M5.27%6.25M71.24%7.4M88.72%9.2M12.87%21.45M18.55%6.31M
Selling and administrative expenses 36.56%4.38M105.80%5.21M143.33%5.82M41.61%12.1M91.01%3.97M24.94%3.21M23.26%2.53M29.45%2.39M30.15%8.55M40.07%2.08M
-General and administrative expense 36.56%4.38M105.80%5.21M143.33%5.82M41.61%12.1M91.01%3.97M24.94%3.21M23.26%2.53M29.45%2.39M30.15%8.55M40.07%2.08M
Research and development costs -2.66%2.96M-64.05%1.75M-68.13%2.17M55.12%20.01M24.92%5.29M-9.70%3.05M114.73%4.87M124.85%6.81M3.75%12.9M10.23%4.23M
Operating profit -17.45%-7.34M5.92%-6.96M13.20%-7.99M-54.60%-32.12M-46.70%-9.26M-5.27%-6.25M-71.24%-7.4M-119.04%-9.2M-15.08%-20.77M-18.55%-6.31M
Net non-operating interest income expense -34.16%264K-68.16%142K330.61%211K123.26%1.19M142.98%294K91.87%401K120.79%446K2,350.00%49K8,983.33%533K4,133.33%121K
Non-operating interest income -32.93%279K-66.45%155K227.54%226K105.04%1.26M124.29%314K83.26%416K97.44%462K392.86%69K--615K--140K
Non-operating interest expense 0.00%15K-18.75%13K-25.00%15K-13.41%71K5.26%20K-16.67%15K-50.00%16K66.67%20K1,266.67%82K533.33%19K
Other net income (expense) -39.17%1.07M-97.78%374K170.70%8.35M43.69%-5.8M-681.94%-12.56M25.64%1.75M5,860.99%16.81M-13.81%-11.81M-10.3M-1.61M
Gain on sale of security -39.17%1.07M-97.78%374K170.70%8.35M43.69%-5.8M-681.94%-12.56M25.64%1.75M5,860.99%16.81M-13.81%-11.81M---10.3M---1.61M
Income before tax -46.75%-6.01M-165.42%-6.45M102.72%570K-20.25%-36.73M-176.03%-21.53M5.47%-4.1M356.77%9.86M-43.83%-20.96M-69.14%-30.54M-46.36%-7.8M
Income tax
Net income -46.75%-6.01M-165.42%-6.45M102.72%570K-20.25%-36.73M-176.03%-21.53M5.47%-4.1M356.77%9.86M-43.83%-20.96M-69.14%-30.54M-46.36%-7.8M
Net income continuous Operations -46.75%-6.01M-165.42%-6.45M102.72%570K-20.25%-36.73M-176.03%-21.53M5.47%-4.1M356.77%9.86M-43.83%-20.96M-69.14%-30.54M-46.36%-7.8M
Minority interest income
Net income attributable to the parent company -46.75%-6.01M-165.42%-6.45M102.72%570K-20.25%-36.73M-176.03%-21.53M5.47%-4.1M356.77%9.86M-43.83%-20.96M-69.14%-30.54M-46.36%-7.8M
Preferred stock dividends 26.30%1.1M047.10%887K8.33%208K867K0
Other preferred stock dividends 060K5.93M0
Net income attributable to common stockholders -46.75%-6.01M-311.86%-6.45M102.41%510K-20.42%-37.82M-176.03%-21.53M7.01%-4.1M168.52%3.04M-43.37%-21.17M-73.95%-31.41M-46.36%-7.8M
Basic earnings per share 28.26%-0.33-165.00%-0.52056.25%-5.6-18.17%-1.890864.62%-0.46127.59%0.837.11%-6.1-6.67%-12.854.29%-1.6
Diluted earnings per share 28.26%-0.3365.33%-0.5291.80%-0.556.25%-5.6-18.17%-1.890864.62%-0.4648.28%-1.537.11%-6.1-6.67%-12.854.29%-1.6
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +1.02%
Sample Name
Sample Code
 +0.89%
Sample Name
Sample Code
 +0.86%
4
Palo Alto Networks
PANW
+0.66%
5
Broadcom
AVGO
+0.55%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.72%
Sample Name
Sample Code
 +8.72%
Sample Name
Sample Code
 +7.79%
4
Zai Lab
ZLAB
+6.69%
5
Taiwan Semiconductor
TSM
+6.38%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -